Related Experiment Video
Updated: Jul 5, 2026

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
Published on: November 2, 2020
A genome-wide in vivo CRISPR activation screen identifies BACE1 as a therapeutic vulnerability of lung cancer brain
Shawn C Chafe1,2, Kui Zhai1,2,3, Nikoo Aghaei4
1Department of Surgery, McMaster University, Hamilton, ON L8S 4L8, Canada.
Abstract:
Brain metastasis occurs in up to 40% of patients with non-small cell lung cancer (NSCLC). Considerable genomic heterogeneity exists between the primary lung tumor and respective brain metastasis; however, the identity of the genes capable of driving brain metastasis is incompletely understood. Here, we carried out an in vivo genome-wide CRISPR activation screen to identify molecular drivers of brain metastasis from an orthotopic xenograft model derived from a patient with NSCLC. We found that activating expression of the Alzheimer's disease-associated beta-secretase 1 (BACE1) led to a substantial increase in brain metastases. Furthermore, genetic and pharmacological inhibition of BACE1 blocked NSCLC brain metastasis. Mechanistically, we identified that BACE1 acts through epidermal growth factor receptor to drive this metastatic phenotype. Together, our data highlight the power of in vivo CRISPR activation screening to unveil molecular drivers and potential therapeutic targets of NSCLC brain metastasis.
Insights
Activating beta-secretase 1 (BACE1), linked to Alzheimer's disease, significantly increased brain metastases in non-small cell lung cancer (NSCLC). Inhibiting BACE1 blocked this spread, revealing a potential therapeutic target.
Area of Science:
- Oncology
- Neuroscience
- Genetics
Background:
- Brain metastasis is a frequent complication in non-small cell lung cancer (NSCLC), affecting up to 40% of patients.
- Significant genomic differences exist between primary lung tumors and their brain metastases, with key drivers often unknown.
Purpose of the Study:
- To identify molecular drivers of brain metastasis in non-small cell lung cancer (NSCLC).
- To explore the role of beta-secretase 1 (BACE1) in promoting NSCLC brain metastasis.
- To investigate BACE1 as a potential therapeutic target for NSCLC brain metastasis.
Main Methods:
- Utilized an in vivo genome-wide CRISPR activation screen in an orthotopic xenograft model derived from an NSCLC patient.
- Assessed the impact of gene activation on the development of brain metastases.
- Investigated the effects of genetic and pharmacological inhibition of BACE1 on NSCLC brain metastasis.
- Elucidated the downstream signaling pathway involving epidermal growth factor receptor (EGFR).
Main Results:
- Activation of beta-secretase 1 (BACE1) substantially increased the incidence of brain metastases in the NSCLC model.
- Genetic and pharmacological inhibition of BACE1 effectively blocked NSCLC brain metastasis.
- BACE1 was found to mediate its pro-metastatic effects through the epidermal growth factor receptor (EGFR) pathway.
Conclusions:
- In vivo CRISPR activation screening is a powerful tool for discovering metastasis drivers.
- Beta-secretase 1 (BACE1) is a key molecular driver of non-small cell lung cancer (NSCLC) brain metastasis.
- Targeting BACE1, potentially in combination with EGFR pathways, offers a promising therapeutic strategy for NSCLC brain metastasis.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

